Health ❯ Healthcare

Neurodegenerative Diseases

Alzheimer's Disease Dementia Parkinson's Disease Cognitive Impairment Alzheimer's Research Pathophysiology Diagnosis Optic Nerve Disorders Neuroprotection Multiple Sclerosis Genetic Disorders Amyloid Pathology Aphasia Research Innovations Amyotrophic Lateral Sclerosis Research Drug Development Clinical Trials Therapeutics

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

The decision follows Phase 3 evidence, aligning the UK regimen with other major markets.

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

First Noninvasive MRI Maps Brain’s Tiniest Vessel Pulses, Tying Aging and Hypertension to Deep White Matter

Eye and Blood Levels of SLIT2 Track Cognition in Middle-Aged Adults, Study Finds

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia